Subjective cognitive decline, brain imaging biomarkers, and cognitive functioning in patients with a history of vascular disease: the SMART-Medea study

Kim Blom,Huiberdina L. Koek,Maarten H.T. Zwartbol,Yolanda van der Graaf,Lara Kesseler,Geert Jan Biessels,Mirjam I. Geerlings,the SMART Study Group,Yolanda van der Graaf,Diederick E. Grobbee,Guy E.H.M. Rutten,Frank L.J. Visseren,Gert Jan de Borst,L. Jaap Kappelle,Tim Leiner,Pieter A. Doevendans
DOI: https://doi.org/10.1016/j.neurobiolaging.2019.07.011
IF: 5.133
2019-12-01
Neurobiology of Aging
Abstract:<p>We estimated associations of subjective cognitive decline (SCD) with neuro-imaging markers of dementia and cognitive functioning in patients with a history of vascular disease without objective cognitive impairment. Within the SMART-Medea study, 599 patients (62±9 years) had 1.5T brain MRI and cognitive testing at baseline and after 8 years of follow-up. Using multiple regression analyses, we estimated cross-sectional and longitudinal associations of SCD according to research criteria with volumes of total brain, hippocampus, white matter hyperintensities (WMH), and presence of lacunes; and with memory, executive functioning, information processing speed, and working memory. SCD was associated with increased risk of lacunes at baseline (RR=1.48, 95% CI: 1.03; 2.12), but not during follow-up. No significant associations with volumes of WMH, total brain or hippocampus were observed. SCD was cross-sectional associated with poorer executive functioning and speed, but not during follow-up. More prospective studies are needed to further elucidate the relationship between SCD, brain imaging markers, and cognitive decline and the role of SCD in the preclinical stage of Alzheimer's disease.</p>
neurosciences,geriatrics & gerontology,gerontology
What problem does this paper attempt to address?